282 related articles for article (PubMed ID: 28297569)
1. Administration of Adult Human Bone Marrow-Derived, Cultured, Pooled, Allogeneic Mesenchymal Stromal Cells in Critical Limb Ischemia Due to Buerger's Disease: Phase II Study Report Suggests Clinical Efficacy.
Gupta PK; Krishna M; Chullikana A; Desai S; Murugesan R; Dutta S; Sarkar U; Raju R; Dhar A; Parakh R; Jeyaseelan L; Viswanathan P; Vellotare PK; Seetharam RN; Thej C; Rengasamy M; Balasubramanian S; Majumdar AS
Stem Cells Transl Med; 2017 Mar; 6(3):689-699. PubMed ID: 28297569
[TBL] [Abstract][Full Text] [Related]
2. Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease.
Gupta PK; Dutta S; Kala S; Nekkanti M; Desai SC; Mahapatra SS; Dhar A; Raju R; M R; Behera A; P S; Raviraja NS; Viswanathan P; Chandrashekar M; Thej C; K V P; Abraham J; Boggarapu H; Udaykumar K
Stem Cells Transl Med; 2021 Dec; 10(12):1602-1613. PubMed ID: 34519179
[TBL] [Abstract][Full Text] [Related]
3. Human bone marrow-derived, pooled, allogeneic mesenchymal stromal cells manufactured from multiple donors at different times show comparable biological functions in vitro, and in vivo to repair limb ischemia.
Thej C; Balasubramanian S; Rengasamy M; Walvekar A; Swamynathan P; Raj SS; Shahani P; Siddikuzzaman ; Kolkundkar U; Seetharam RN; Gupta PK; Majumdar AS
Stem Cell Res Ther; 2021 May; 12(1):279. PubMed ID: 33971964
[TBL] [Abstract][Full Text] [Related]
4. Early Results of Clinical Application of Autologous Whole Bone Marrow Stem Cell Transplantation for Critical Limb Ischemia with Buerger's Disease.
Heo SH; Park YS; Kang ES; Park KB; Do YS; Kang KS; Kim DI
Sci Rep; 2016 Jan; 6():19690. PubMed ID: 26791280
[TBL] [Abstract][Full Text] [Related]
5. Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model.
Kim SW; Han H; Chae GT; Lee SH; Bo S; Yoon JH; Lee YS; Lee KS; Park HK; Kang KS
Stem Cells; 2006 Jun; 24(6):1620-6. PubMed ID: 16497946
[TBL] [Abstract][Full Text] [Related]
6. Label extension, single-arm, phase III study shows efficacy and safety of stempeucel® in patients with critical limb ischemia due to atherosclerotic peripheral arterial disease.
Gupta PK; Shivashankar P; Rajkumar M; Mahapatra SS; Desai SC; Dhar A; Krishna V; Raviraja NS; Bhat S; Viswanathan P; Kannan S; Abraham J; Boggarapu H; Manjuprasad MS; Udaykumar K
Stem Cell Res Ther; 2023 Apr; 14(1):60. PubMed ID: 37005673
[TBL] [Abstract][Full Text] [Related]
7. Effect of autologous bone-marrow cell transplantation on ischemic ulcer in patients with Buerger's disease.
Saito Y; Sasaki K; Katsuda Y; Murohara T; Takeshita Y; Okazaki T; Arima K; Katsuki Y; Shintani S; Shimada T; Akashi H; Ikeda H; Imaizumi T
Circ J; 2007 Aug; 71(8):1187-92. PubMed ID: 17652879
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells.
Motukuru V; Suresh KR; Vivekanand V; Raj S; Girija KR
J Vasc Surg; 2008 Dec; 48(6 Suppl):53S-60S; discussion 60S. PubMed ID: 19084740
[TBL] [Abstract][Full Text] [Related]
9. Stem cell therapy for treatment of thromboangiitis obliterans (Buerger's disease).
Cacione DG; do Carmo Novaes F; Moreno DH
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012794. PubMed ID: 30378681
[TBL] [Abstract][Full Text] [Related]
10. A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia.
Gupta PK; Chullikana A; Parakh R; Desai S; Das A; Gottipamula S; Krishnamurthy S; Anthony N; Pherwani A; Majumdar AS
J Transl Med; 2013 Jun; 11():143. PubMed ID: 23758736
[TBL] [Abstract][Full Text] [Related]
11. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results.
Isner JM; Baumgartner I; Rauh G; Schainfeld R; Blair R; Manor O; Razvi S; Symes JF
J Vasc Surg; 1998 Dec; 28(6):964-73; discussion 73-5. PubMed ID: 9845647
[TBL] [Abstract][Full Text] [Related]
12. Sequential intravenous allogeneic mesenchymal stromal cells as a potential treatment for thromboangiitis obliterans (Buerger's disease).
Martin-Rufino JD; Lozano FS; Redondo AM; Villaron EM; Rueda R; Fernandez-Samos R; Sanchez-Guijo F
Stem Cell Res Ther; 2018 May; 9(1):150. PubMed ID: 29848379
[TBL] [Abstract][Full Text] [Related]
13. Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans.
Durdu S; Akar AR; Arat M; Sancak T; Eren NT; Ozyurda U
J Vasc Surg; 2006 Oct; 44(4):732-9. PubMed ID: 16926085
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia.
Kajiguchi M; Kondo T; Izawa H; Kobayashi M; Yamamoto K; Shintani S; Numaguchi Y; Naoe T; Takamatsu J; Komori K; Murohara T
Circ J; 2007 Feb; 71(2):196-201. PubMed ID: 17251666
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Autologous Cell-based Therapy in Patients with No-option Critical Limb Ischaemia: A Meta-Analysis.
Wahid FSA; Ismail NA; Wan Jamaludin WF; Muhamad NA; Mohamad Idris MA; Lai NM
Curr Stem Cell Res Ther; 2018; 13(4):265-283. PubMed ID: 29532760
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemia.
Kinoshita M; Fujita Y; Katayama M; Baba R; Shibakawa M; Yoshikawa K; Katakami N; Furukawa Y; Tsukie T; Nagano T; Kurimoto Y; Yamasaki K; Handa N; Okada Y; Kuronaka K; Nagata Y; Matsubara Y; Fukushima M; Asahara T; Kawamoto A
Atherosclerosis; 2012 Oct; 224(2):440-5. PubMed ID: 22877866
[TBL] [Abstract][Full Text] [Related]
17. A Prospective, Nonrandomized, no Placebo-Controlled, Phase I/II Clinical Trial Assessing the Safety and Efficacy of Intramuscular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Patients With Severe Buerger's Disease.
Ra JC; Jeong EC; Kang SK; Lee SJ; Choi KH
Cell Med; 2017; 9(3):87-102. PubMed ID: 28713639
[TBL] [Abstract][Full Text] [Related]
18. The Efficacy of Percutaneous Transluminal Angioplasty on the Limb Salvage and Recovery of Symptoms in Patients With Buerger's Disease With Critical Limb Ischemia.
Rodoplu O; Yildiz CE; Oztas DM; Conkbayir C; Unal O; Ulukan MO; Meric M; Ugurlucan M; Kirbas A
J Invasive Cardiol; 2020 Jun; 32(6):E158-E167. PubMed ID: 32479418
[TBL] [Abstract][Full Text] [Related]
19. In vivo efficacy of endothelial growth medium stimulated mesenchymal stem cells derived from patients with critical limb ischemia.
Al-Rifai R; Nguyen P; Bouland N; Terryn C; Kanagaratnam L; Poitevin G; François C; Boisson-Vidal C; Sevestre MA; Tournois C
J Transl Med; 2019 Aug; 17(1):261. PubMed ID: 31399109
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel®): preclinical and clinical trial in osteoarthritis of the knee joint.
Gupta PK; Chullikana A; Rengasamy M; Shetty N; Pandey V; Agarwal V; Wagh SY; Vellotare PK; Damodaran D; Viswanathan P; Thej C; Balasubramanian S; Majumdar AS
Arthritis Res Ther; 2016 Dec; 18(1):301. PubMed ID: 27993154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
